Summary of Study ST001795
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001139. The data can be accessed directly via it's Project DOI: 10.21228/M8GH59 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST001795 |
Study Title | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) |
Study Type | Untargeted lipidomics analysis |
Study Summary | Untargeted lipid profiling of mesenteric mice lymph from mice fed with CHOW, HFD and HFD supplemented with COx-2 inhibitor drug Celecoxib. It is proposed that Celecoxib can protect from deleterious morphological changes in lymphatic system caused by obesity/HFD. |
Institute | Monash Institute of Pharmaceutical Sciences |
Department | Drug Delivery, Disposition and Dynamics |
Laboratory | Trevaskis Lab, Creek Lab |
Last Name | Anderson |
First Name | Dovile |
Address | 6 Anderson |
dovile.anderson@gmail.com | |
Phone | 8671141 |
Submit Date | 2021-05-12 |
Num Groups | 3 |
Total Subjects | 26 |
Num Males | 26 |
Publications | Manuscript NATMETAB-A20022406A Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential novel treatment target in obesity |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2021-06-02 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Treatment |
---|---|---|
SA167157 | Celecoxib_HFD_3 | Celecoxib_HFD |
SA167158 | Celecoxib_HFD_9 | Celecoxib_HFD |
SA167159 | Celecoxib_HFD_2 | Celecoxib_HFD |
SA167160 | Celecoxib_HFD_5 | Celecoxib_HFD |
SA167161 | Celecoxib_HFD_4 | Celecoxib_HFD |
SA167162 | Celecoxib_HFD_8 | Celecoxib_HFD |
SA167163 | Celecoxib_HFD_1 | Celecoxib_HFD |
SA167164 | Celecoxib_HFD_7 | Celecoxib_HFD |
SA167165 | Celecoxib_HFD_6 | Celecoxib_HFD |
SA167149 | CFD_3 | CFD |
SA167150 | CFD_2 | CFD |
SA167151 | CFD_4 | CFD |
SA167152 | CFD_7 | CFD |
SA167153 | CFD_8 | CFD |
SA167154 | CFD_1 | CFD |
SA167155 | CFD_6 | CFD |
SA167156 | CFD_5 | CFD |
SA167166 | HFD_7 | HFD |
SA167167 | HFD_8 | HFD |
SA167168 | HFD_9 | HFD |
SA167169 | HFD_6 | HFD |
SA167170 | HFD_1 | HFD |
SA167171 | HFD_2 | HFD |
SA167172 | HFD_3 | HFD |
SA167173 | HFD_4 | HFD |
SA167174 | HFD_5 | HFD |
Showing results 1 to 26 of 26 |